Identification of structure–activity relationships for adverse effects of pharmaceuticals in humans. Part A: Use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities

✍ Scribed by Carling J. Ursem; Naomi L. Kruhlak; Joseph F. Contrera; Philip M. MacLaughlin; R. Daniel Benz; Edwin J. Matthews

• Book ID: 113965415
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 315 KB
• Volume: 54
• Category: Article
• ISSN: 0273-2300
• DOI: 10.1016/j.yrtph.2008.12.009